We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $6.66B
1-Year Est. Return 360.84%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+360.84%
3 Year Est. Return
+1,707.27%
5 Year Est. Return
+3,210.42%
10 Year Est. Return
+53,055.89%
AUM
$6.85B
AUM Growth
+$678M
Cap. Flow
-$555M
Cap. Flow %
-8.1%
Top 10 Hldgs %
43.77%
Holding
155
New
30
Increased
19
Reduced
23
Closed
29

Top Buys

Rank Stock Value
1
OM icon
Outset Medical
OM
+$156M
2
CRSP icon
CRISPR Therapeutics
CRSP
+$119M
3
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$90.9M
4
RLAY icon
Relay Therapeutics
RLAY
+$88.8M
5
CHRS icon
Coherus Oncology
CHRS
+$57.5M

Top Sells

Rank Stock Value
1
ZGNX
Zogenix, Inc.
ZGNX
+$133M
2
KOD icon
Kodiak Sciences
KOD
+$124M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$68.6M
4
VAPO
Vapotherm, Inc. Common Stock
VAPO
+$54.9M
5
IOVA icon
Iovance Biotherapeutics
IOVA
+$52.8M

Sector Composition

Rank Sector Weight
1 Healthcare 84.2%
2 Miscellaneous 14.63%
3 Consumer Staples 0.6%
4 Financials 0.25%
5 Industrials 0.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APLS
126
DELISTED
Apellis Pharmaceuticals
APLS
– –
-11,418
Closed -$373K
AVDL
127
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-8,681
Closed -$133K
AXSM icon
128
Axsome Therapeutics
AXSM
$10.7B
– –
-50,000
Closed -$4.11M
BDTX icon
129
Black Diamond Therapeutics
BDTX
$113M
– –
-1,104,656
Closed -$44M
CUE icon
130
Cue Biopharma
CUE
$230M
– –
-879
Closed -$646K
DVAX
131
DELISTED
Dynavax Technologies
DVAX
– –
-176,950
Closed -$1.57M
FULC icon
132
Fulcrum Therapeutics
FULC
$288M
– –
-894,118
Closed -$15.8M
KRMD icon
133
KORU Medical Systems
KRMD
$146M
– –
-74,813
Closed -$672K
MDT icon
134
Medtronic
MDT
$120B
– –
-20,000
Closed -$1.83M
MRNA icon
135
PUT
Moderna
MRNA
$57.4B
– –
-100,000
Closed -$6.42M
NGNE icon
136
Neurogene
NGNE
$674M
– –
-26,871
Closed -$8.92M
PHR icon
137
Phreesia
PHR
$642M
– –
-70,000
Closed -$1.98M
VIR icon
138
Vir Biotechnology
VIR
$1.77B
– –
-13,024
Closed -$534K
YMAB
139
DELISTED
Y-mAbs Therapeutics
YMAB
– –
-355,366
Closed -$15.4M
RVNC
140
DELISTED
Revance Therapeutics, Inc.
RVNC
– –
-65,839
Closed -$1.61M
DMTK
141
DELISTED
DermTech, Inc. Common Stock
DMTK
– –
-487,121
Closed -$6.45M
KRTX
142
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
– –
-6,944
Closed -$774K
VAPO
143
DELISTED
Vapotherm, Inc. Common Stock
VAPO
– –
-167,345
Closed -$54.9M
BLU
144
DELISTED
BELLUS Health Inc.
BLU
– –
-1,125,000
Closed -$11.6M
CCXI
145
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-10,252
Closed -$590K
VCRA
146
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
– –
-290,000
Closed -$6.15M
LMNX
147
DELISTED
Luminex Corp
LMNX
– –
-18,926
Closed -$616K
IMMU
148
PUT
DELISTED
Immunomedics Inc
IMMU
– –
-100,000
Closed -$3.54M
MNTA
149
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
– –
-30,637
Closed -$1.02M
ZGNX
150
DELISTED
Zogenix, Inc.
ZGNX
– –
-4,907,139
Closed -$133M
2 3 4 5
6

Similar funds

QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.59B AUM 31.9% 1-Year Est. Return
KGA
K5 Global Advisor Miami Beach, Florida $6.59B AUM
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

Perceptive Advisors's Q3 2020 Portfolio in Review

As of Q3 2020, Perceptive Advisors held 155 positions worth $6.85B, up 11% from $6.17B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Perceptive Advisors withdrew a net $555M in Q3 2020, closing 29 positions and reducing 23 holdings. Its most notable exit was Zogenix, Inc., an estimated $133M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 84% a quarter earlier, followed by Miscellaneous and Consumer Staples.

Against the trend, Perceptive Advisors opened a new position in Outset Medical worth $142M.

  • Perceptive Advisors's largest Q3 2020 buy was Outset Medical: 189,855 shares worth $142M.
  • Perceptive Advisors added most to Mirati Therapeutics, Inc. Common Stock in Q3 2020, an estimated $90.9M increase.
  • Perceptive Advisors's biggest Q3 2020 reduction was Kodiak Sciences, cutting an estimated $124M.
  • Perceptive Advisors fully exited Zogenix, Inc. in Q3 2020, selling an estimated $133M.
  • Perceptive Advisors's ten largest holdings make up 44% of its $6.85B portfolio in Q3 2020.
  • Perceptive Advisors opened 30 new positions and closed 29 in Q3 2020.
  • Perceptive Advisors's portfolio value rose 11% quarter-over-quarter to $6.85B.

Based on Perceptive Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.